© American Consumer News, LLC dba MarketBeat® 2010-2021. View our full suite of financial calendars and market data tables, all for free. Looking Into Why AcelRx Pharmaceuticals's Stock is Trading Higher Today, AcelRx Announces an Investigator-Initiated Study of DSUVIA® in Cardiac Surgery Enhanced Recovery Regimen, AcelRx Announces Underwritten Public Offering of Common Stock. AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in healthcare institutions, today announced that management will present an overview of AcelRx Pharmaceuticals, followed by a fireside chat with Dr. Pamela Palmer. ACRX 1.67 0.01 (0.60%). Let 10 time trading champion Chuck Hughes show you how to start making more income. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Learn about financial terms, types of investments, trading strategies and more. A production slowdown says “yes.”, AcelRx Pharmaceuticals to Present at LD Micro Main Event, AcelRx Pharmaceuticals Announces Partnership with the National Rural Health Association. AcelRx Pharmaceuticals Inc. SEC filings breakout by MarketWatch. ACRX NEWS. ACRX ($1.76) is undervalued by 14.99% relative to our estimate of its Fair Value price of $2.07 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety ... ACRX News. We and our partners will store and/or access information on your device through the use of cookies and similar technologies, to display personalised ads and content, for ad and content measurement, audience insights and product development. You can opt out at any time. View AcelRx Pharmaceuticals, Inc. ACRX investment & stock information. ACRX=TURD=SHIT=CRAP =LATRINE =STOOL=LAVATORY =POOPNikjun, published March 12, 2021 What Else are ACRX Traders Talking About? SPECIAL DONATION REQUEST UPDATE: Please help American Consultants Rx achieve it’s biggest goal yet of donating … To enable Verizon Media and our partners to process your personal data select 'I agree', or select 'Manage settings' for more information and to manage your choices. You can change your choices at any time by visiting Your Privacy Controls. Export data to Excel for your own analysis. Could This Be the Biggest US Gold Discovery in Years? WildEarth PET DEALS: BREAKING NEWS: Click today to request your free ACRX discount prescription card and save up to 80% off of your medicine! Is the Options Market Predicting a Spike in AcelRx (ACRX) Stock? A high-level overview of AcelRx Pharmaceuticals, Inc. (ACRX) stock. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Find the latest news headlines from AcelRx Pharmaceuticals, Inc. Common Stock (ACRX) at Nasdaq.com. Post-Market 0.02 (1.20%) 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. SPECIAL DONATION REQUEST UPDATE: Please help American Consultants Rx achieve it’s biggest goal yet… AcelRx Pharmaceuticals (NASDAQ ACRX) News Headlines Today Source: All Sources Trusted Sources MarketBeat.com Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. AcelRx Pharmaceuticals Announces Commentary in Practical Pain Management on Previously Published Clinical Data on Preoperative Administration of DSUVIA®, AcelRx Pharmaceuticals: The $1 Million Questions, AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates, Analysts Are Upgrading AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) After Its Latest Results, AcelRx Pharmaceuticals to Present at Credit Suisse 29th Annual Virtual Healthcare Conference, AcelRx Pharmaceuticals, Inc. (ACRX) CEO Vincent Angotti on Q3 2020 Results - Earnings Call Transcript, AcelRx Pharmaceuticals (ACRX) Reports Q3 Loss, Misses Revenue Estimates, AcelRx Pharmaceuticals EPS misses by $0.02, misses on revenue, AcelRx Pharmaceuticals, Inc. to Host Earnings Call, AcelRx Pharmaceuticals Reports Third Quarter 2020 Financial Results, AcelRx to Host Third Quarter 2020 Financial Results Call and Webcast on Thursday, November 5, 2020, AcelRx Pharmaceuticals (ACRX) May Report Negative Earnings: Know the Trend Ahead of Q3 Release, Aclaris (ACRS) Begins Phase II Study on Eczema Candidate. Fundamental company data provided by Zacks Investment Research. Real time AcelRx Pharmaceuticals (ACRX) stock price quote, stock graph, news & analysis. 4 Upgrades In Big Tech Moving The Markets Now, 7 Electric Vehicle (EV) Stocks That Are Ready to Rebound, 7 Sports Betting Stocks That Will Shine Beyond March Madness, 7 Stocks That Cathie Wood is Buying And You Should Too, 7 Internet of Things Stocks That Are a Perfect Fit to Our Connected Future, 7 Undervalued Stocks That Deserve More Attention, 7 Semiconductor Stocks Set to Gain From the Chip Shortage, 7 Great Dividend Stocks to Buy For a Comfortable Retirement, 7 Penny Stocks That Don’t Care About Robinhood, 7 Hotel Stocks Just Waiting For the Vaccine, 7 Stocks to Watch When Student Debt Forgiveness Gets Passed, 7 Healthcare Stocks Delivering Innovation in 2021, AcelRx Pharmaceuticals Stock Is Estimated To Be Possible Value Trap, AcelRx Pharmaceuticals (NASDAQ:ACRX) Shares Pass Above 200 Day Moving Average of $1.70, AcelRx Pharmaceuticals Announces Clinical Data Reporting High Ratings for Healthcare Professional and Patient Satisfaction Following Use of DSUVIA® for Acute Pain in Hospital Settings, AcelRx Announces Presentation and Fireside Chat at the Benzinga Biotech Small Cap Conference, AcelRx Pharmaceuticals (NASDAQ:ACRX) Stock Price Down 5.8%, AcelRx Pharmaceuticals (NASDAQ:ACRX) Shares Gap Down to $2.18, AcelRx Pharmaceuticals (NASDAQ:ACRX) Announces Earnings Results, Meets Estimates, AcelRx Pharmaceuticals (ACRX) Reports Q4 Loss, Lags Revenue Estimates, AcelRx Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results, AcelRx Pharmaceuticals (NASDAQ:ACRX) Stock Price Up 10.7%, AcelRx Pharmaceuticals (ACRX) Set to Announce Quarterly Earnings on Monday, AcelRx to Host Fourth Quarter and Full Year 2020 Financial Results Call and Webcast on March 15, 2021, Will AcelRx Pharmaceuticals (ACRX) Report Negative Q4 Earnings? Learn everything you need to know about successful options trading with this three-part video course. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. ACRX News: AcelRx Announces Presentation and Fireside Chat at the Benzinga Biotech Small Cap Conference: 03/22/2021 02:48:00 PM: ACRX News: Annual Report (10-k) 03/15/2021 05:29:22 PM: ACRX News: Current Report Filing (8-k) 03/15/2021 04:07:50 PM: ACRX News: AcelRx Pharmaceuticals EPS in-line, misses on revenue: 03/15/2021 04:05:27 PM What You Should Know, AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Short Interest Update, SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AcelRx Pharmaceuticals, Inc. (ACRX), AcelRx Announces an Investigator-Initiated Study of DSUVIA® in Patients Undergoing Plastic Surgery Procedures, Peninsula pain drug maker made 'false and misleading claims,' FDA says. Email Address. To see all exchange delays and terms of use please see disclaimer. TODAY All Day BREAKING NEWS: Click today to request your free ACRX discount prescription card and save up to 80% off of your medicine! ACRX currently public float of 88.85M and currently shorts hold a 11.82% ratio of that float. Is It Profit-Taking Time on Avis Budget Group Stock? Get daily stock ideas top-performing Wall Street analysts. The company’s shares closed last Tuesday at $1.92. Is AcelRx Pharmaceuticals (ACRX) A Good Stock To Buy Now? SPECIAL DONATION REQUEST UPDATE: Please help American Consultants Rx achieve it’s biggest goal yet … VICE News BEST DEALS UPDATE: BREAKING NEWS: Click today to request your free ACRX discount prescription card and save up to 80% off of your medicine! Thinking about buying stock in Tenax Therapeutics, Boxlight Corp, Blink Charging, Pacific Ethanol, or AcelRx Pharmaceuticals? Learn more. ACRX stocks went down by -11.62% for the week, with a monthly jump of 70.40% and a quarterly performance of 18.33%, while its annual performance rate touched 25.29%. Click and follow American Consultants Rx on Twitter (under medicinehelp) for the latest news in the industry. Get the latest AcelRx Pharmaceuticals Inc (ACRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. See how this tiny, unknown gold company secured a prime land package right next door to the world’s two largest gold producers in Nevada’s famed Carlin Trend where 84 Million gold ounces have already been extracted. Get the latest AcelRx Pharmaceuticals, Inc. (ACRX) stock news and headlines to help you in your trading and investing decisions. Start Your Risk-Free Trial Subscription Here, McCormick Stock Is Seasoned Just Right For Value Investors, Houghton Mifflin Harcourt Stock Up 24% Yesterday - Here's Why, Canoo Stock Sinks After No-Revenue Quarter, 3 Telecom Infrastructure Stocks Signaling Big Gains. View the latest AcelRx Pharmaceuticals Inc. (ACRX) stock price, news, historical charts, analyst ratings and financial information from WSJ. Reid Park Zoo PET DEALS: BREAKING NEWS: Click today to request your free ACRX discount prescription card and save up to 80% off of your medicine! Reid Park Zoo PET DEALS: BREAKING NEWS: Click today to request your free ACRX discount prescription card and save up to 80% off of your medicine! View real-time stock prices and stock quotes for a full financial overview. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Want to see which stocks are moving? REDWOOD CITY, Calif., Nov. 5, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today reported its third quarter… Read more « © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Receive ACRX News and Ratings via Email. ACRX fair valueFair Value of ACRX stock based on Discounted Cash Flow (DCF) 1M-10.27% 1M-10.27% 3M +36.41% All. This brand new report is your guide to finding the lithium supply chain winners… including one with a massive new mine. Please log in to your account or sign up in order to add this asset to your watchlist. H.C. Wainwright analyst Ed Arce maintained a Buy rating on Acelrx (ACRX – Research Report) today and set a price target of $7.00. "Should I trade "ACRX" stock today?" All rights reserved. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. ... Webull provides a variety of real-time ACRX stock news. Get the latest AcelRx Pharmaceuticals, Inc. ACRX detailed stock quotes, stock data, … 2d ago. Looking for new stock ideas? , /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company, today announced that it will release fourth quarter financial results after market close on . "ACRX" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. AcelRx Pharmaceuticals, Inc. Common Stock (ACRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Do Not Sell My Information. Information about your device and internet connection, including your IP address, Browsing and search activity while using Verizon Media websites and apps. ACRX’s Market Performance. When Will AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Become Profitable? Reflecting on AcelRx Pharmaceuticals' (NASDAQ:ACRX) Share Price Returns Over The Last Three Years, AcelRx awarded ~$3.6M contract for DSUVIA by U.S. Army, AcelRx announces DSUVIA's expanded access, Receive Analysts' Upgrades and Downgrades Daily. These 2 Penny Stocks Could Surge Over 300%, Say Analysts, AcelRx Announces $10 Million Registered Direct Common Stock Offering, AcelRx Pharmaceuticals Announces Publication of Clinical Data on Decreased Postoperative Opioid Requirements and Enhanced Postanesthesia Recovery Following Perioperative Use of DSUVIA®, Are Elon Musk and Tesla running out of lithium? At this point, we expect that initial stocking orders for the U.S. Army SKOs alone will approximate $30 million over the next 3 years based on the timing of troop deployment schedules. Valuation. Advanced breast cancer imaging tools could catapult this stock into the stratosphere. Our Accessibility Statement See what's happening in the market right now with MarketBeat's real-time news feed. 7 months ago. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. SPECIAL DONATION REQUEST UPDATE: Please help American Consultants Rx achieve it’s biggest goal yet… View which stocks are hot on social media with MarketBeat's trending stocks report. Yahoo is part of Verizon Media. According to our live Forecast System, Acelrx Pharmaceuticals Inc stock is a bad long-term (1-year) investment *. NWS News Corp $24.73 / -0.19 (-0.76%) 03/15/21 Facebook, News Corp reach multi-year agreement in Australia 03/15/21 News Corp jumps 3.5% to $25.58 after disclosing Rupert Murdoch insider buy 03/15/21 News Corp executive chairman buys 500K shares of common stock 02/17/21 News Corp, Google agree to three-year news partnership Shares of AcelRx Pharmaceuticals (NASDAQ:ACRX) were trading down by 16% as of 11:40 a.m. EST on Wednesday after the company announced the pricing of a … SPECIAL DONATION REQUEST UPDATE: Please help American Consultants Rx achieve it’s biggest goal… Learn more. You can receive the latest news about Acelrx Pharma through multiple platforms. Receive a free world-class investing education from MarketBeat. Spend less time looking for fashion,news,entertainment, and deals online at ACRX NEWS. ACRX | Complete AcelRx Pharmaceuticals Inc. stock news by MarketWatch. Find out more about how we use your information in our Privacy Policy and Cookie Policy. Acelrx Pharmaceuticals NASDAQ Updated Mar 26, 2021 11:43 PM. Get short term trading ideas from the MarketBeat Idea Engine. American Humane PET DEALS UPDATE: SPECIAL NEWS BULLETIN: Click today to request your free ACRX discount prescription card and save up to 80% off of your medicine! ACRX: Get the latest AcelRx Pharmaceuticals stock price and detailed information including ACRX news, historical charts and realtime prices. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. SPECIAL DONATION REQUEST UPDATE: Please help American Consultants Rx achieve it’s biggest goal yet of donating… Do Options Traders Know Something About AcelRx (ACRX) Stock We Don't? View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. $1.62. Identify stocks that meet your criteria using seven unique stock screeners. Other tickers frequently mentioned alongside ACRX are , IBIO, HOTH and NOVN. Find real-time ACRX - AcelRx Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. Sign-up to receive the latest news and ratings for ACRX and its competitors with MarketBeat's FREE daily newsletter. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. REDWOOD CITY, Calif., Feb. 17, 2021 /PRNewswire/ — AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in healthcare institutions, today announced an … Today, the average trading volume of ACRX was 4.48M shares. View the ACRX U.S. Securities and Exchange Commission reporting information. Sign up today and receive his Trade of the Day eletter and a free copy of “Options Trading Made Easy”. **Click on ACRX Recognition Gallery today and discovery the humanitarian video series created by Charles Myrick of ACRX.”There are a lot of organizations that are doing an extraordinary job in the community but are usually overlooked. At this point, we expect that initial stocking orders for the U.S. Army SKOs alone will approximate $30 million over the next 3 years based on the timing of troop deployment schedules. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. Other Notable StockTweets About ACRX AcelRx Announces Pricing of $27.5 Million Public Offering of Common Stock, Why Is It Moving? 8 months ago. Today's Range.